Industry: Biotechnology Region: Italy Transaction Price: USD 1 million Transaction Method: Equity Investment
Project introduction:
An Italian company, which is a leader in the production of active pharmaceutical ingredients (API), the use of synthesis and biotechnology in the contract development and manufacturing (CDMO) market and the field of generic drugs.
As CDMO, various bacterial, yeast and fungal systems are used to provide microbial fermentation development and amplification solutions for proteins and (high-value) s mall molecules. In two CDMO stations, the fermentation capacity of 4,500 cubic meters is provided, equipped with laboratory, pilot-scale and commercial-scale fermenters, and equipped with a series of DSP kits.
The company has specialized pharmaceutical and food-grade manufacturing areas, and provides a complete set of chemical synthesis and biological processing services, which meet cGMP(FDA and EMA approval), FSSC22.000 and Jewish and food standards.
Cooperation mode:
Looking for partners who are interested in this technology to jointly promote cooperation in various forms such as distribution agency and technical cooperation.